Ligand validation:6PTK

9RN: 3,6-anhydro-alpha-D-galactopyranose

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6PTK_9RN_D_610	70%	53%	0.107	0.925	0.72	1.08	-	2	0	0	100%	1
6PTK_9RN_C_609	62%	48%	0.12	0.91	0.8	1.21	-	1	0	0	100%	1
6PTK_9RN_A_602	61%	50%	0.11	0.899	0.74	1.16	-	2	0	0	100%	1
6PTK_9RN_B_607	54%	55%	0.116	0.878	0.71	1.03	-	1	0	0	100%	1
6PT9_9RN_B_602	77%	48%	0.1	0.956	0.78	1.21	-	3	0	0	91%	0.9091
6B0J_9RN_C_503	90%	50%	0.08	0.98	0.54	1.36	-	2	0	0	91%	0.9091
6B0K_9RN_A_504	72%	52%	0.103	0.943	0.82	1.05	-	1	0	0	91%	0.9091

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.